Dr Reddys Laboratories

BSE: 500124 | NSE: DRREDDY | ISIN: INE089A01023 | SECTOR: Biotechnology & Drugs

₹ 6,198.90

-94.60 (-1.5%)
30 Apr 2024, 03:29 PM IST
View all metrics

Key Metrics

Influencer Count

-

Simple Moving Averages

DaysBSENSE

56,081.496,082.23
106,067.246,067.13
206,113.306,114.23
506,231.126,231.66
1006,003.346,003.79
3005,775.565,776.30

News

View all

Company Description

Dr. Reddy’s Laboratories Limited is an India-based global pharmaceutical company. The Company offers a portfolio of products and services, including active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC). Its major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. The Company’s segments include Pharmaceutical Services and Active Ingredients, Global Generics, and Others. The Pharmaceutical Services and Active Ingredients segment primarily consists of the Company’s business of manufacturing and marketing APIs and intermediates. The Global Generics segment consists of the Company’s business of manufacturing and marketing prescription and OTC finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics).

Company Officers